We are live on ! Find out more
TECX

Tectonic Therapeutic

82 hedge funds and large institutions have $241M invested in Tectonic Therapeutic in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

162% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 13

71% more call options, than puts

Call options by funds: $29K | Put options by funds: $17K

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

21% more capital invested

Capital invested by funds: $199M → $241M (+$41.9M)

5% more funds holding

Funds holding: 7882 (+4)

4.7% more ownership

Funds ownership: 60.17%64.87% (+4.7%)

Holders
82
Holders Change
+4
Holders Change %
+5.13%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
34
Reduced
13
Closed
14
Calls
$29K
Puts
$17K
Net Calls
+$12K
Net Calls Change
+$12K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Soleus Capital Management
Connecticut
$1.53M
Millennium Management
27
Millennium Management
New York
$1.49M -$3.31M -163,049 -69%
DMKJ
28
David M. Knott Jr
$1.47M +$689K +34,000 +85%
ACM
29
ADAR1 Capital Management
Texas
$1.46M +$221K +10,902 +17%
Wells Fargo
30
Wells Fargo
California
$1.45M +$811K +40,001 +122%
BFM
31
Boothbay Fund Management
New York
$896K -$697K -34,392 -43%
AC
32
Aldebaran Capital
Indiana
$800K -$12.9K -638 -2%
WHAM
33
Windmill Hill Asset Management
United Kingdom
$795K
SC
34
Stempoint Capital
New York
$795K +$811K +40,000 New
Connor, Clark & Lunn Investment Management (CC&L)
35
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$710K +$21.6K +1,063 +3%
UBS Group
36
UBS Group
Switzerland
$680K +$467K +23,011 +205%
Charles Schwab
37
Charles Schwab
California
$643K +$656K +32,365 New
Wellington Management Group
38
Wellington Management Group
Massachusetts
$567K +$180K +8,885 +45%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$502K +$512K +25,258 New
MCM
40
Monimus Capital Management
New Jersey
$475K +$110K +5,433 +29%
Barclays
41
Barclays
United Kingdom
$435K +$166K +8,181 +60%
Raymond James Financial
42
Raymond James Financial
Florida
$428K +$56.9K +2,809 +15%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$387K -$257K -12,663 -39%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$372K -$1.78M -87,996 -82%
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$365K +$112K +5,515 +43%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$324K +$278K +13,718 +528%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$317K +$322K +15,875 +15,875%
N
48
Nuveen
North Carolina
$284K +$290K +14,304 New
BCM
49
Bridgeway Capital Management
Texas
$246K -$46.3K -2,285 -16%
Marshall Wace
50
Marshall Wace
United Kingdom
$212K -$865K -42,662 -80%

TECX Hedge Fund Activity: Q2 2025 in Review

82 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q2 2025, worth a combined $241M — up 21% from $199M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TECX positions and 14 closed out — a net gain of 4 holders — while 34 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $11.3M. The largest seller was Millennium Management, cutting an estimated $3.31M.

  • 82 institutional investors held Tectonic Therapeutic (TECX) as of Q2 2025, up from 78 in Q1 2025.
  • Funds reported $241M of Tectonic Therapeutic stock for Q2 2025, up 21% quarter-over-quarter.
  • 18 funds opened new Tectonic Therapeutic positions in Q2 2025 and 14 closed out, a net change of +4 holders.
  • The largest Tectonic Therapeutic buyer in Q2 2025 was BlackRock, an estimated $11.3M added.
  • The largest Tectonic Therapeutic seller in Q2 2025 was Millennium Management, an estimated $3.31M sold.

Based on aggregated 13F filings for Q2 2025.